There was a significant drop in CD4+ TFH-TH1 cells at hospitalization among COVID-19 patients as compared to healthy controls, which consistently increased throughout the infection, reaching a level at 6-7 months that was comparable to healthy controls (Figure 3F). This evidence concerns the gene CD4 and COVID-19.